Biosearch Technologies Oligo Synthesis

High-purity NGS oligos without the HPLC price tag When your assay depends on clean, reliable oligos, purification matters. But high performance should not always mean high cost. NxGrade oligos offer a smart middle ground: high purity, low cross-contamination risk and a purpose-built workflow designed for NGS adapters and indexing primers. Get the quality your sequencing needs while keeping purification costs under control.

Reduce cross-contamination risk in your NGS workflow For sensitive applications, even low-level oligo carryover can create doubt in your results. NxGrade oligos are produced using a purpose-built, optimised process designed to deliver high purity with low cross-contamination risk, helping you generate cleaner, more reliable data. For NGS indexing and other demanding workflows, NxGrade delivers the confidence you need without the added cost of HPLC purification.

Every phage display project faces the same challenge: sourcing quality reagents across multiple workflow steps. LGC solves this with competent cells engineered for reproducible library construction and optimized native or recombinant antigens that support demanding selections. Order your complete workflow today to access cells and antigens from one trusted partner.

Reduce vendor complexity in your phage display workflow by sourcing from one supplier. LGC’s end-to-end solution combines engineered competent cells with high-quality antigens, supporting discovery from extensive library generation through final characterization. Choose from amber suppressor (TG1) or non-amber suppressor strains (SS320, ER2738) to fit your workflow needs. Browse configurations and bulk dispensing options today.

Your phage display workflow is only as strong as its weakest link. Why risk library construction with one supplier and antibody screening with another? LGC delivers a complete solution: industry-leading competent cells (TG1, ER2738, SS320) paired with premium antigens from The Native Antigen Company for reliable downstream screening. Generate billions of unique clones using cells engineered for consistent transformation, then validate with native-like antigens optimized for selection accuracy. Order now to streamline your next project.

Sourcing competent cells from one supplier and enzymes from another can create compatibility risks across your mRNA workflows. Successful mRNA therapeutic projects demand integrated competent cells and enzyme systems from a specialized partner. Start with LGC's integrated mRNA synthesis solutions.